Subscribe to RSS

DOI: 10.1055/a-2786-1128
Outcome in Patients with Secundum Type Atrial Septal Defect Referred for Percutaneous or Surgical Closure: A Single-Center Experience
Authors
Funding Information
Abstract
This single-center, retrospective analysis presents data from 611 patients with a secundum type atrial septal defect (ASD II) closure. Included were patients >2 years of age. Patients presented at a median (range) age of 6.95 (2–86) years for interventional closure of ASD II. Out of 611 patients, 215 underwent intracardiac repair based on transthoracic echocardiography (ECHO) findings. Transcatheter device closure was attempted and successfully performed in 300 out of 396 patients (Amplatzer™ Septal Occluder [ASO], n = 290 patients). Follow-up was 3.3 years (1 day–21.8 years) in patients with interventional closure of ASD II and 0.7 years (3 days–14.7 years; p < 0.001; Mann–Whitney) in patients after surgical closure. There was no in-hospital mortality in both groups. One patient, after Amplatzer device closure with an absent aortic rim, developed erosion, which was treated by cardiac surgery and patch closure of ASD II. Two patients showed dislocation of the device. In 231 out of 396 patients, right ventricular dimension normalized completely as determined on the last follow-up visit. Six patients at a median age of 60 (49.4–68.7) years presented with atrial fibrillation, which persisted after ASD II closure. About 26 patients (6.6%) showed pulmonary hypertension (PH), with 1 presenting with coincidental ASD II and severe PH. Closure of ASD II can be accomplished safely by interventional catheterization and intracardiac repair. In most cases, perioperative transthoracic and transesophageal ECHO is sufficient to decide whether a surgical approach or interventional closure is the best option to close the defect.
Keywords
cardiac catheterization/intervention (includes PCI) - congenital heart disease - CHD - pulmonary arteries/veinsContributors' Statement
J.G.: contributed to conceptualization, data curation, formal analysis, writing–original draft, writing–review and editing. V.Z. contributed to conceptualization, data curation, formal analysis, investigation, methodology, supervision, writing–original draft, writing–review and editing. M.F. contributed to data curation, formal analysis, writing–original draft. T.L. contributed to conceptualization, project administration, validation, writing–review and editing. M.G. contributed to conceptualization, data curation, formal analysis, methodology, project administration, resources, writing–original draft, writing–review and editing.
‡ These authors contributed equally to this article.
Publication History
Received: 05 July 2025
Accepted: 11 January 2026
Accepted Manuscript online:
19 January 2026
Article published online:
02 February 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010; 222 (05) 321-326
- 2 van der Linde D, Konings EE, Slager MA. et al. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol 2011; 58 (21) 2241-2247
- 3 Campbell M. Natural history of atrial septal defect. Br Heart J 1970; 32 (06) 820-826
- 4 O'Byrne ML, Shinohara RT, Grant EK. et al. Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database. Am Heart J 2017; 192: 85-97
- 5 Ivy D, Rosenzweig EB, Abman SH. et al. Embracing the challenges of neonatal and paediatric pulmonary hypertension. Eur Respir J 2024; 64 (04) 2401345
- 6 Haworth SG. Pulmonary vascular disease in secundum atrial septal defect in childhood. Am J Cardiol 1983; 51 (02) 265-272
- 7 Rosenzweig EB, Abman SH, Adatia I. et al. Paediatric pulmonary arterial hypertension: Updates on definition, classification, diagnostics and management. Eur Respir J 2019; 53 (01) 1801916
- 8 Evertz R, Reinders M, Houck C. et al. Atrial fibrillation in patients with an atrial septal defect in a single centre cohort during a long clinical follow-up: Its association with closure and outcome of therapy. Open Heart 2020; 7 (02) e001298
- 9 Rosenthal D, Chrisant MR, Edens E. et al. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant 2004; 23 (12) 1313-1333
- 10 Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63 (04) 496-502
- 11 Jalal Z, Hascoët S, Gronier C. et al. Long-term outcomes after percutaneous closure of ostium secundum atrial septal defect in the young: A nationwide cohort study. JACC Cardiovasc Interv 2018; 11 (08) 795-804
- 12 Turner DR, Owada CY, Sang Jr CJ, Khan M, Lim DS. Closure of secundum atrial septal defects with the AMPLATZER Septal Occluder: A prospective, multicenter, post-approval study. Circ Cardiovasc Interv 2017; 10 (08) e004212
- 13 Takaya Y, Akagi T, Nakagawa K. et al. Feasibility of transcatheter closure for absent aortic rim in patients with atrial septal defect. Catheter Cardiovasc Interv 2021; 97 (05) 859-864
- 14 Garre S, Gadhinglajkar S, Sreedhar R, Krishnamoorthy KM, Pillai VV. Atrial septal defect occluder device embolization: Experience of a tertiary care cardiac center. Ann Card Anaesth 2023; 26 (02) 149-154
- 15 Olejnik P, Tittel P, Venczelova Z. et al. Long-term follow-up of percutaneous secundum-type atrial septal defect closure using Amplatzer Septal Occluder since 1995: A single-centre study. Cardiol Young 2024; 34 (03) 643-646
- 16 Grieshaber P, Jaschinski C, Farag M. et al. Surgical treatment of atrial septal defects. Rev Cardiovasc Med 2024; 25 (10) 350
- 17 de Beco G, Mambour N, Vô C. et al. Recent experience and follow-up after surgical closure of secundum atrial septal defect in 120 children. Pediatr Cardiol 2018; 39 (07) 1440-1444
- 18 Villablanca PA, Briston DA, Rodés-Cabau J. et al. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int J Cardiol 2017; 241: 149-155
- 19 Ooi YK, Kelleman M, Ehrlich A. et al. Transcatheter versus surgical closure of atrial septal defects in children: A value comparison. JACC Cardiovasc Interv 2016; 9 (01) 79-86
- 20 Bacha E. Transcatheter versus surgical closure of atrial septal defects. JACC Cardiovasc Interv 2016; 9 (01) 87-88
- 21 Bier ML. Cardiac erosions with the Amplatzer Septal Occluder: Adverse Events in the Manufacturer and User Facility Device Experience (MAUDE) Database since the 2012. FDA Review STRUCTURAL HEART 2021; 5: 85-89
- 22 Auriau J, Bouvaist H, Aaberge L. et al. Cardiac erosions after transcatheter atrial septal defect closure with the Occlutech Figulla Flex device. JACC Cardiovasc Interv 2019; 12 (14) 1397-1399
- 23 Kister T, Dähnert I, Lurz P. Fatal erosion atrial septal defect device. Catheter Cardiovasc Interv 2016; 87 (05) 951-954
- 24 Kumar P, Orford JL, Tobis JM. Two cases of pericardial tamponade due to nitinol wire fracture of a Gore Septal Occluder. Catheter Cardiovasc Interv 2020; 96 (01) 219-224
- 25 Hirsch R, Bagby MC, Zussman ME. Fenestrated ASD II closure in a child with idiopathic pulmonary hypertension and exercise desaturation. Congenit Heart Dis 2011; 6 (02) 162-166
- 26 Wacker J, Humpl T, Berger RMF. et al. Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry. Front Cardiovasc Med 2024; 11: 1344014
- 27 Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999; 340 (11) 839-846
- 28 Berger F, Vogel M, Kretschmar O, Dave H, Prêtre R, Dodge-Khatami A. Arrhythmias in patients with surgically treated atrial septal defects. Swiss Med Wkly 2005; 135 (11-12): 175-178